Jessica Fleming

Affiliate Assistant Professor, Epidemiology



PhD Epidemiology, University of Washington, 2009
MSc Tropical Public Health, Harvard University, 1998
BS Biology, Wake Forest University, 1990



2001 Westlake Avenue, Suite 200
PO Box 900922
Seattle, WA 98109
View Website »


Jessica Fleming is a Product Development Director and the Maternal Immunization Delivery Lead in the Policy, Access and Introduction program within PATH’s Center for Vaccine Introduction and Access. With over twenty five years of experience working in international public health, she provides public health leadership in evaluating the impact of vaccines and health technologies appropriate for low resource settings and generating evidence to assist countries in preparing for new vaccine introduction. Dr. Fleming currently leads the Advancing Maternal Immunization (AMI) collaboration that enables efficient, well-informed decisions around the introduction of maternal immunizations in low- and middle-income countries, with a special emphasis on maternal vaccines for respiratory syncytial virus. She leads formative research on maternal vaccine decision-making and acceptance. Her work includes conducting clinical studies to quantify the impact of vaccines and improve their performance in low-income populations and contributing to global guidance on the use of safe injection technologies and waste management. Before joining PATH in 2003, Dr. Fleming lived and worked in a number of complex emergency and humanitarian relief settings in Africa and Asia. Dr. Fleming holds a Doctorate of Philosophy in epidemiology from the University of Washington and a Master of Science in tropical public health from the Harvard School of Public Health with a concentration in infectious disease epidemiology and international health. She is an affiliate assistant professor in the Epidemiology Department at the University of Washington.

Research Interests

Maternal immunization, Vaccine policy making; Vaccine evaluation; increasing access to health technologies in low resource settings

Recent Publications (PubMed)

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective.
(2021 Mar 24)
Hum Vaccin Immunother
Khan S, Fleming JA, Engmann CM

Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.
(2020 Nov 23)
J Pediatr Hematol Oncol
Graham RT, Bell EH, Webb A, Zhao Y, Timmers C, Fleming JL, Sells BE, Robison NJ, Palmer JD, Finlay JL, Chakravarti A

A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma.
(2021 Jan)
Mol Cancer Res 19(1): 48-60
Cui T, Bell EH, McElroy J, Liu K, Sebastian E, Johnson B, Gulati PM, Becker AP, Gray A, Geurts M, Subedi D, Yang L, Fleming JL, Meng W, Barnholtz-Sloan JS, Venere M, Wang QE, Robe PA, Haque SJ, Chakravarti A

Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage.
PLoS One 15(8): e0237718
Baral R, Fleming J, Khan S, Higgins D, Hendrix N, Pecenka C

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
(2020 Oct 10)
J Clin Oncol 38(29): 3407-3417
Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming JL, Timmers CD, Becker AP, Salavaggione AL, Liu Z, Aldape K, Brachman DG, Gertler SZ, Murtha AD, Schultz CJ, Johnson D, Laack NN, Hunter GK, Crocker IR, Won M, Chakravarti A

Show complete publication list

In the News

No news articles at this time.